Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85243096 | 8524309 | 6 | F | 2009 | 20160912 | 20120420 | 20160914 | EXP | FR-JNJFOC-20110600712 | JANSSEN | 51.00 | YR | A | M | Y | 98.00000 | KG | 20160914 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85243096 | 8524309 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | UNKNOWN | 103772 | 10 | MG/KG | LYOPHILIZED POWDER | ||||||
| 85243096 | 8524309 | 2 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 85243096 | 8524309 | 3 | C | COTAREG | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 0 | 160 | MG | QD | ||||||||
| 85243096 | 8524309 | 4 | C | ZANIDIP | LERCANIDIPINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 85243096 | 8524309 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 34 UNITS MORNINGS, 64 UNITS EVENINGS | 0 | ||||||||||
| 85243096 | 8524309 | 6 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 18 UNITS MORNINGS, 10U MIDDAY AND 23 U EVENINGS | 0 | ||||||||||
| 85243096 | 8524309 | 7 | C | DIAMICRON | GLICLAZIDE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 85243096 | 8524309 | 8 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 85243096 | 8524309 | 9 | C | COLOFOAM | HYDROCORTISONE ACETATE | 1 | 0 | ||||||||||||
| 85243096 | 8524309 | 10 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 85243096 | 8524309 | 1 | Colitis ulcerative |
| 85243096 | 8524309 | 2 | Hypertension |
| 85243096 | 8524309 | 3 | Hypertension |
| 85243096 | 8524309 | 4 | Hypertension |
| 85243096 | 8524309 | 5 | Diabetes mellitus |
| 85243096 | 8524309 | 6 | Diabetes mellitus |
| 85243096 | 8524309 | 7 | Diabetes mellitus |
| 85243096 | 8524309 | 8 | Hypertension |
| 85243096 | 8524309 | 10 | Dyslipidaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 85243096 | 8524309 | OT |
| 85243096 | 8524309 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 85243096 | 8524309 | Carotid arteriosclerosis | |
| 85243096 | 8524309 | Colitis ulcerative | |
| 85243096 | 8524309 | Myocardial infarction | |
| 85243096 | 8524309 | Vascular stent restenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 85243096 | 8524309 | 1 | 20090529 | 0 |